Ignite Creation Date:
2024-05-06 @ 11:13 AM
Last Modification Date:
2024-10-26 @ 12:42 PM
Study NCT ID:
NCT03461952
Status:
TERMINATED
Last Update Posted:
2024-02-22
First Post:
2018-03-05
Brief Title:
Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood NIMBLe
Sponsor:
Canadian Cancer Trials Group
Organization:
Canadian Cancer Trials Group
Organization Data
Organization:
Canadian Cancer Trials Group
Class:
NETWORK
Study ID:
I235
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Canadian Cancer Trials Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Personal Genome Diagnostics | UNKNOWN |
| Cancer Research Institute New York City | OTHER |
| Bristol-Myers Squibb | INDUSTRY |